CDSCO monthly lab alert
CDSCO NSQ alert, October 2025: 211 drug batches flagged
By Blacklisted editorial team· Published 20 Nov 2025· Updated 3 Nov 2026· Source: CDSCO NSQ portal
In its October 2025 alert, the Central Drugs Standard Control Organisation listed 211 drug batches that failed quality tests, 63 at central laboratories and 148 at state drug-testing laboratories, from 158 manufacturers across 145 products. The most common failure was assay, and the most-represented manufacturing state was Himachal Pradesh. Products flagged include Calcium Carbonate & Vitamin D3 Tablets (Aemcal-D3), Calcium Carbonate & Vitamin D3 Tablets IP (SENCAL - 500), Calcium & Vitamin D3 Tablets (TISE-CAL).
211
Batches flagged
63 / 148
Central / state labs
Assay
Top reason
158
Manufacturers
Batches per month, last 12 alerts
Nov 2024Oct 2025 · 211
Full list of NSQ batches, October 2025
Download CSV| Product | Batch | Manufacturer | Reason declared NSQ | Tested by |
|---|---|---|---|---|
| Voligesic Gel (Diclofenac Diethylamine. Linseed Oil, Methyl Salicylate & Menthol Gel) | Batch DE4G12Mfg Jul 2024 · Exp Jun 2027 | Scott-Edil Pharmacia LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Vecuronium Bromide Injection IP 10 mg | Batch L25DU002Mfg Feb 2025 · Exp Jan 2027 | Nixi Laboratories Pvt.Ltd VPO. Mouza OgliHimachal Pradesh | The sample does not conform to I.P. with respect to the Test for Water Content and Assay of Vecuronium BromideAssay | CDL, KolkataCDSCO lab |
| VITACRINE LC (Alpha Lipoic Acid, Folic Acid, Methylcobalamin, Pyridoxine Hydrochloride & Vitamin D3 Tablets) | Batch BD250297BMfg Feb 2025 · Exp Jan 2027 | Bioaltus Pharmaceuticals Pvt. LtdHimachal Pradesh | Test for Disintegration onlyDisintegration | DTL, Bengaluru, KarnatakaState lab |
| VALET-PM (Paracetamol and Diclofenac Potassium Tablets) | Batch MAW40523Mfg May 2023 · Exp Apr 2026 | Suraksha Pharma Pvt. LtdUttarakhand | Test for Disintegration onlyDisintegration | DTL, Bengaluru, KarnatakaState lab |
| V-Floxacin -BH (Enrofloxacin & Bromhexine HCL Oral Liquid) | Batch VBL-053Mfg Mar 2025 · Exp Aug 2026 | Varsha Labs LLPKarnataka | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Trypsin-Chymotrypsin Tablets (CHYMORAL FORTE DS) | Batch WBB1E020Mfg Dec 2024 · Exp Nov 2026 | Windlas Biotech Limited (Plant-2)Uttarakhand | The sample is not of standard quality for the reason stated under 'Description'.Description | CDL, KolkataCDSCO lab |
| Tramadol Hydrochloride and Acetaminophen Tablets (Paradol-T) | Batch JTN25-096Mfg Jun 2025 · Exp May 2027 | Janya Biocare Pvt. LtdUttarakhand | Test For DissolutionDissolution | NCT of DelhiState lab |
| Telmisartan and Amlodipine Tablets (Teluse AM) | Batch T24119Mfg Nov 2024 · Exp Oct 2026 | Tiba Pharmaceuticals Pvt.Ltd | Assay of Amlodipine besylate 1.72 mg (34.40%) found as claimed 5 mg)Assay | DTL Baddi H.PState lab |
| Tadalafil Tablets I.P. 20 mg (TADAFIRE- 20) | Batch 1528Mfg May 2025 · Exp Apr 2028 | Alpha Pharmaceuticals 41Haryana | The sample does not conform to I.P. with respect to the DissolutionDissolution | CDL, KolkataCDSCO lab |
| Stenflam SP | Batch MMT-9435Mfg Feb 2024 · Exp Jan 2026 | Mayoford Pharma Near Railway CrossingHimachal Pradesh | The sample fails in the Assay contents of Paracetamol.Assay | MDTL Kathua,Jammu and KashmirState lab |
| Shicold-Plus | Batch RL23222Mfg Dec 2023 · Exp Nov 2025 | Rachil Pharma 18-19 PHASE-1 Ind.Area Sansarpur Terrace HP | NSQOther | DTL Baddi H.PState lab |
| Sertralinc Tablets IP 50mg(Teslin-50) | Batch 111T241Mfg Oct 2024 · Exp Sep 2027 | Vega Biotec Pvt. Ltd. 23Gujarat | DissolutionDissolution | DTL, Thrissur, KeralaState lab |
| Serratiopeptidase Tablets IP | Batch MT240928Mfg Oct 2024 · Exp Sep 2026 | Plot No.11Uttarakhand | Sample fails the test DisintegrationDisintegration | DTL, Thiruvananthapuram, KeralaState lab |
| Seram DP | Batch SRDPT602Mfg Nov 2024 · Exp Oct 2026 | Tulbros Formulations | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua,Jammu and KashmirState lab |
| SILNAC-P (Aceclofenac & Paracetamol Tablets IP) | Batch TSC-250577Mfg Feb 2025 · Exp Jan 2027 | Prochem Pharmaceuticals Pvt. LtdUttarakhand | Test for Dissolution? onlyDissolution | DTL, Bengaluru, KarnatakaState lab |
| Rosuvastatin 10 mg, Aspirin 150 mg and Clopidogrel 75 mg Capsules | Batch SIBP24283Mfg Jun 2024 · Exp May 2026 | Bioaltus Pharmaceuticals Pvt. LtdSikkim | Assay for RosuvastatinAssay | DTL, Bengaluru, KarnatakaState lab |
| Ramipril Tablets IP (Rexre-2.5) | Batch MB-13247Mfg Jan 2025 · Exp Dec 2027 | Medistream Bioscience | Sample does not conform IP standard as it fails the test Dissolution and Assay of RamipirilAssay | DTL, Thrissur, KeralaState lab |
| Rabeprazole Sodium (EC) and Domperidone (SR) Capsules (TOTORAB-DSR PLUS) | Batch 240612Mfg Jun 2024 · Exp May 2026 | Saiyam Healthcare | ContentOther | SDTL, PunjabState lab |
| Rabeprazole Sodium & Domperidone Tablets (Asterab-D) | Batch BCT-24-1906Mfg Mar 2025 · Exp Feb 2027 | Biocenna Healthcare Pvt.Ltd.Kh.No.218Uttarakhand | Assay for Rabeprazole SodiumAssay | SDTL,Andhra Pradesh, VijayawadaState lab |
| Rabeprazole Gastro-resistant Tablets IP (RABIMIST-20) | Batch TG24-1514EMfg Jul 2024 · Exp Jun 2026 | Athens Life SciencesHimachal Pradesh | Test for Dissolution and AssayAssay | DTL, Bengaluru, KarnatakaState lab |
| Rabeprazole Gastro- resistant Tablets IP 20 Mg | Batch RABP45003Mfg Oct 2024 · Exp Sep 2026 | Sunrise International Labs LtdTelangana | The sample does not comply DissolutionDissolution | DCL TelanganaState lab |
| Primaquine Tablets IP 7.5mg | Batch MT445Mfg Oct 2024 · Exp Sep 2027 | Maxwell Life Science Pvt. Ltd. T-53 & T-81Maharashtra | The sample does not conform to the IP with respect to Assay of PrimaquineAssay | DTL, JaipurState lab |
| Pregabalin & Methlcobalamin Capsules IP (Neujan Capsules) | Batch MMC-1957Mfg Jan 2024 · Exp Dec 2025 | Mayoford PharmaHimachal Pradesh | Test for Uniformity of WeightUniformity of weight/content | DTL, Bengaluru, KarnatakaState lab |
| Povidone Iodine Solution IP | Batch 2503003Mfg Mar 2025 · Exp Feb 2027 | Biodeal Pharmaceuticals Pvt. LtdHimachal Pradesh | Sample fails the test AssayAssay | RDTL, Ernakulam, KeralaState lab |
| Povidone Iodine & Metronidazole Solution (IU Liquid) | Batch GLO-002Mfg Apr 2025 · Exp Mar 2027 | Gentech Healthcare Pvt Ltd | The sample does not conform to the IP with respect to Assay.Assay | DTL, JaipurState lab |
| Povidone - Iodine Gargle Sepsadone 2% | Batch DLE-4008Mfg Feb 2025 · Exp Jan 2027 | Daffohils Laboratories Pvt. LtdUttarakhand | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Polygeline Intravenous Infusion (3.5% w/v Polygeline colloidal solution with electrolytes) (PENTACIL) | Batch 24EPT020Mfg Nov 2024 · Exp Oct 2026 | Pentagon Labs Ltd. 16C/16D | The sample does not conform to claim as per Patent and Proprietary in respect to the Test of Particulate matter and Assay of Potassium, ChlorideAssay | RDTL, ChandigarhCDSCO lab |
| Paracetamol, Phenyephrine and Chlorpheniramine Suspension IP (Maticold Suspension) | Batch ALE012CMfg May 2025 · Exp Apr 2026 | Haustus Biotech Pvt. Ltd | AssayAssay | DTL Baddi H.PState lab |
| Paracetamol Tablets IP 650mg, | Batch PCT25092Mfg May 2025 · Exp Apr 2027 | Vivek Pharmachem (India) LtdRajasthan | Test for Dissolution of TabletsDissolution | DTL, Bengaluru, KarnatakaState lab |
| Paracetamol Tablets IP 650mg (Parvis-650) | Batch SPT-36695Mfg Oct 2023 · Exp Sep 2025 | Shervotee PharmaceuticalsHimachal Pradesh | DissolutionDissolution | SFTRL, Odisha BhubaneswarState lab |
| Paracetamol Tablets IP 500 mg, | Batch BTH-19Mfg Feb 2025 · Exp Jan 2027 | Bengal Chemicals And Pharmaceuticals E-35 Industrial Area Haridwar-249401 UKUttarakhand | The Sample Received Does Not Conform To I.P. 2022 Specification With Respect To The Test For Dissolution Only.Dissolution | CDTL, HyderabadCDSCO lab |
| Paracetamol Tablets IP (Leemol-500) | Batch AOPT24013SMfg Dec 2023 · Exp Nov 2026 | Leeford Healthcare LtdHimachal Pradesh | AssayAssay | SDTL Raipur ChhattisgarhState lab |
| Paracetamol Tablets I.P. (500 mg) | Batch PCT1210Mfg Aug 2024 · Exp Jul 2026 | Unicure India Ltd. C-21Uttar Pradesh | The sample does not conform to I.P with respect to the test for Dissolution.Dissolution | CDTL, IndoreCDSCO lab |
| Paracetamol Tablets I.P 650 mg (Alpa-650 Tablets) | Batch 2501032Mfg Jan 2025 · Exp Dec 2027 | Aban PharmaceuticalsKerala | Test for Dissolution of TabletsDissolution | DTL, Bengaluru, KarnatakaState lab |
| Paracetamol Tablets I.P -500 mg | Batch DGT 24-25Mfg Nov 2024 · Exp Oct 2026 | Ornate Labs Pvt. LtdBihar | The Sample does not conform to I.P specification with respect to "Dissolution" for ParacetamolDissolution | BDCL, PATNAState lab |
| Paracetamol Tablets I.P -500 mg | Batch DGT 24-232Mfg Nov 2024 · Exp Oct 2026 | Ornate Labs Pvt. LtdBihar | The Sample does not conform to I.P specification with respect to "Dissolution" for ParacetamolDissolution | BDCL, PATNAState lab |
| Paracetamol Paediatric Oral Suspension IP (LOWFE-250) | Batch CL-24098Mfg Feb 2025 · Exp Jan 2027 | Casid Pharmaceuticals Private LimitedTamil Nadu | Failed in AssayAssay | DTL, PuducherryState lab |
| Paracetamol Infusion I.P (1.0% w/v)-Neomol I.V. | Batch T383L935Mfg Mar 2025 · Exp Feb 2027 | Truelixir Life Sciences Private. LimitedMaharashtra | Test for SterilitySterility | DTL, Bengaluru, KarnatakaState lab |
| Paracetamol I.P 650 mg (SINDOL 650 TABLETS) | Batch ALT0841Mfg Apr 2024 · Exp Mar 2026 | Arcon LabsHimachal Pradesh | The Sample does not conform to I.P specification with respect to "Dissolution" for ParacetamolDissolution | BDCL PATNAState lab |
| Paracetamol I.P 650 mg (PC-WIN 650) | Batch VGT 241580BMfg Aug 2024 · Exp Jul 2026 | Vrindavan GlobalHimachal Pradesh | The Sample does not conform to I.P specification with respect to "Dissolution" for ParacetamolDissolution | BDCL, PATNAState lab |
| Paracetamol I.P 500 mg (PARA 500) | Batch NBRT-018Mfg May 2023 · Exp Apr 2026 | Laborate Pharmaceuticals India LtdHimachal Pradesh | The Sample does not conform to I.P specification with respect to "Dissolution" for ParacetamolDissolution | BDCL, PATNAState lab |
| Paracetamol I.P 500 mg (PARA 500) | Batch NBRT-018Mfg May 2023 · Exp Apr 2026 | Laborate Pharmaceuticals India LtdHimachal Pradesh | The Sample does not conform to I.P specification with respect to "Dissolution" for ParacetamolDissolution | BDCL, PATNAState lab |
| Pantoprazole Gastro-resistant and Domperidone Tablets IP | Batch DL-57Mfg Oct 2024 · Exp Sep 2026 | Dutch Formulations 32Himachal Pradesh | The sample does not conform to claim as per Patent and Proprietary in respect to the Disintegration (Acid stage), Assay of Domperidone, Pantoprazole Sodium Calculated As Pantoprazole.Assay | RDTL, ChandigarhCDSCO lab |
| Pantoprazole Gastro-Resistant Tablets IP (Astepan-40) | Batch BCT25-0153Mfg Apr 2025 · Exp Mar 2027 | Biocenna Healthcare Pvt.Ltd.Kh.No.218Uttarakhand | Dissolution for PantoprazoleDissolution | SDTL,Andhra Pradesh, VijayawadaState lab |
| Oxcarbazepine Tablets IP 150 mg (OXCARBAJAJ 150) | Batch OXA01A25Mfg Jan 2025 · Exp Dec 2026 | Bajaj Healthcare Ltd. R.S. No. 1818Gujarat | The Sample Received Does Not Conform To I.P. 2022 Specification With Respect To The Description Only.Description | CDTL, HyderabadCDSCO lab |
| Ovocet-M (Montelukast Sodium & Levocetirizine Hydrochloride Tablets IP) | Batch LV24MT-048CMfg Dec 2024 · Exp Nov 2026 | L.V. Life SciencesHimachal Pradesh | Test for Dissolution of Montelukast onlyDissolution | DTL, Bengaluru, KarnatakaState lab |
| Ofloxacin and Ornidazole Tablets IP (Oflogard-O) | Batch TLT1005BMfg Dec 2024 · Exp Nov 2026 | Amster LabsHimachal Pradesh | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab |
| Ofloxacin and Ornidazole Tablets (02 Tablets) | Batch E41580Mfg Oct 2024 · Exp Sep 2028 | Medley Pharmaceuticals Ltd. Lane no 3Jammu & Kashmir | The Sample does not conform to I.P specification with respect to identification and content of Ofloxacin and OrnidazoleIdentification | BDCL, PATNAState lab |
| Ofloxacin and Ornidazole Tablets (02 Tablets) | Batch E40114Mfg Jan 2024 · Exp Dec 2026 | Medley Pharmaceuticals Ltd. Lane no 3Jammu & Kashmir | The Sample does not conform to I.P specification with respect to identification and content of Ofloxacin and OrnidazoleIdentification | BDCL, PATNAState lab |
| Nuromine PG 37.5 | Batch MLS-241642Mfg Mar 2025 · Exp Feb 2027 | Maskon Life Sciences Pvt. Ltd. Kh. No. 69-70 KhatakheriUttarakhand | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua,Jammu and KashmirState lab |
| Nitrazepam I.P. 10mg tablets(NITRVET 10) | Batch AXZ24003PMfg Jan 2024 · Exp Jun 2028 | Anglo-French Drugs & Industries LtdKarnataka | The Sample does not conform to I.P specification with respect to identification and content of NitrzepamIdentification | BDCL, PATNAState lab |
| Nitrazepam I.P. 10mg tablets(NITRVET 10) | Batch AXZ24003PMfg Jan 2024 · Exp Jun 2028 | Anglo-French Drugs & Industries LtdKarnataka | The Sample does not conform to I.P specification with respect to identification and content of NitrzepamIdentification | BDCL, PATNAState lab |
| Nitrazepam I.P. 10mg tablets(NITRVET 10) | Batch 10233PMfg Oct 2022 · Exp Mar 2027 | Anglo-French Drugs & Industries LtdKarnataka | The Sample does not conform to I.P specification with respect to identification and content of NitrzepamIdentification | BDCL, PATNAState lab |
| Nimuris Cold & Flu Tablets | Batch GT027502Mfg Feb 2025 · Exp Jan 2027 | Asian Pharma Kh. No -105-106Himachal Pradesh | NSQOther | DTL Baddi H.PState lab |
| Nicofast-5 (Nicorandil Tablets IP) | Batch ONTT2404Mfg Mar 2025 · Exp Feb 2027 | Goodman PharmaceuticalsPuducherry | Dissolution & ContentDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Neckline Lip Fashion Lipstick [Neckline Ultima III Lip color (on carton)] | Batch NL05Mfg May 2025 · Exp Apr 2028 | Kanero CosmeticsDelhi | Test For Break Load Value.Other | NCT of DelhiState lab |
| Mymi D (Alpha Lipoic Acid, Pyridoxine Hydrochloride, Methylcobalamin, Folic Acid & Vitamin D3 Tablets) | Batch HT24673Mfg Dec 2024 · Exp Nov 2026 | HBC Healthcare Pvt. LtdGujarat | Test for Disintegration onlyDisintegration | DTL, Bengaluru, KarnatakaState lab |
| Montelukast and Levocetirizine Tablets IP (Montilax Tablets) | Batch ATD052BMfg Apr 2024 · Exp Mar 2026 | Haustus Biotech Pvt. Ltd | AssayAssay | DTL Baddi H.PState lab |
| Montelukast Sodium & Levocetirizine Dihydrochloride Tablets IP (ZAL-M Tablets) | Batch JMT-2504057Mfg Apr 2025 · Exp Mar 2027 | JMM LaboratoriesHimachal Pradesh | The sample does not conform to claim as per I.P. 2022 with respect to the test for "Assay and Dissolution" for Montelukast.Assay | RDTL, GuwahatiCDSCO lab |
| Montecas-L Syrup (Levocetirizine & Montelukast) | Batch BCRL2407068Mfg Jul 2024 · Exp Jun 2026 | Casca Remedies Pvt. LtdHaryana | Assay of Montelukast onlyAssay | DTL, Bengaluru, KarnatakaState lab |
| Misoprostol Tablets IP 100mcg | Batch TM-1480005Mfg Feb 2025 · Exp Jan 2027 | Centurion Remedies Pvt. LtdGujarat | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Meurozen-D3 Softgel Capsules (Methylcobalamin, Alpha Lipoic Acid, Folic Acid, Pyridoxine HCL & Vitamin D3 Softgel Capsules) | Batch HPDC25248Mfg Mar 2025 · Exp Feb 2027 | Healthwise PharmaHimachal Pradesh | Test for Disintegration and with respect to label claim of Assay for Pyridoxine HCL and Vitamin D3Assay | DTL, Bengaluru, KarnatakaState lab |
| Metoprolol Succinate (ER) & Amlodipine Besylate Tablets IP (Metorell-AM 50 Tablets) | Batch 77BG08Mfg Jun 2025 · Exp May 2027 | Sarv PharmaceuticalsUttarakhand | Uniformity of Weight? and ?Test for Dissolution for AmlodipineDissolution | DTL, Bengaluru, KarnatakaState lab |
| Methylcobalamin Tablets USP 500 mcg | Batch G250050/2Mfg Apr 2025 · Exp Mar 2027 | Vee Excel Drugs & Pharmaceuticals (P) Ltd. B-1/AUttar Pradesh | The sample does not conform to claim as per USP 2024 in respect to the Assay of MethylcobalaminAssay | RDTL, ChandigarhCDSCO lab |
| Metformin Hydrochloride (SR) & Glimepride Tablets IP (Yathoglim-M3) | Batch T25C554AMfg Mar 2025 · Exp Feb 2027 | Bajaj FormulationsUttarakhand | Sample fail the test Assay of Glimepiride.Assay | RDTL, Ernakulam, KeralaState lab |
| Meloxicam Paracetamol & Serratiopeptidase Bolus (vet) | Batch T-25095Mfg May 2025 · Exp Apr 2027 | Minil Laboratories Pvt. Ltd. 26Jammu & Kashmir | The sample does not conform to the claim with respect to Description as it show physical instabillity in the form of Mottling.Description | DTL, JaipurState lab |
| Lycopene, Anti-oxidant, Multivitamin and Multimineral Syrup (Lycoanvit Plus Syrup) | Batch OL-24419Mfg Sep 2024 · Exp Feb 2026 | Orchid Bio-Tech Ltd. 65Delhi | The sample does not conform to claim as per Patent and Proprietary in respect to the Test of Identification and Assay of Folic acid, Cyanocobalamin, Copper Sulphate, Vitamin D3, Calcium PantothenateAssay | RDTL, ChandigarhCDSCO lab |
| Luliconazole Cream IP 1% w/w | Batch H017Mfg Apr 2024 · Exp Mar 2026 | Merril Pharma Pvt. LtdUttarakhand | The sample does not conform to I.P 2022 with respect to the content of Luliconazole.Other | CDTL, IndoreCDSCO lab |
| Losartan Potassium & Amlodipine Tablets IP | Batch TL-1470007Mfg Dec 2023 · Exp Nov 2026 | Centurion Remedies Pvt. LtdGujarat | The sample does not conform to the IP with respect to Assay and Dissolution.Assay | DTL, JaipurState lab |
| Loperamide Hydrochloride Tablets IP 2 MG (Lomorex Tablets) | Batch CT-7350Mfg Apr 2024 · Exp Mar 2027 | Chemetac Pharmaceuticals 42 Maina PurUttar Pradesh | The sample does not comply as per I.P. 2022 with respect to the test for "Dissolution" of Loperamide Hydrochloride.Dissolution | RDTL, GuwahatiCDSCO lab |
| Loperamide HCI Tablet IP (KARLOP) | Batch T-17075Mfg Apr 2025 · Exp Mar 2027 | Karnani Pharmaceuticals(P) Ltd. 38Uttarakhand | The sample does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab |
| Liposomal Amphotericin B Injection 50 mg (Gufisome 50 mg/vial) | Batch AA241096BMfg Dec 2024 · Exp Nov 2026 | Gufic Biosciences Limited N.H.No. 08 KabilporeGujarat | The sample does not conform to Manufacturer specification with respect to Clarity of solution, pH, reconstitution time, Particulate Matter, Free Drug and Assay of amphotericin B.Assay | CDL, KolkataCDSCO lab |
| Liposomal Amphotericin B Injection 50 Mg (Gufisome) | Batch AB240590BMfg Dec 2024 · Exp Nov 2026 | Gufic Biosciences Ltd. National Highway No. 8Gujarat | The sample does not conform to Manufacturer's Specification with respect to test for pH, Free Drugs, Particulate Matter, Reconstitution Time, Clarity Of Solution and AssayAssay | CDL, KolkataCDSCO lab |
| Lindane Lotion USP 1% | Batch LNE-1020Mfg Aug 2025 · Exp Jul 2027 | Wings Biotech LLPHimachal Pradesh | The above product is official in IP 2022 (Addendum 2024 W.e.f july 2024) but it is claimed as USP as on Manufacturing date.Other | SDTL, PunjabState lab |
| Levocetirizine Dihydrochloride Tab (Wineet-L) | Batch YLT25023Mfg Mar 2025 · Exp Feb 2027 | YL PharmaHimachal Pradesh | The sample does not conform to the IP as it does not contain Levocetirizine DihydrochlorideOther | DTL, JaipurState lab |
| Levocetirizine Dihydrochloride & Montelukast Sodium Orally Disintegrating Tablets (MONSTAR-LC KID) | Batch TL-23109Mfg Dec 2023 · Exp Nov 2025 | Horizon Bioceuticals Pvt. LtdHimachal Pradesh | Average weight and Assay (for Levocetirizine Dihydrochloride)Assay | DTL, PuducherryState lab |
| Labetalol Injection IP | Batch L0422420FMfg Dec 2024 · Exp Nov 2026 | Protech TelelinksHimachal Pradesh | pHpH | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab |
| L-Lysine Hydrochloride Ointment (Lycimond) | Batch 25006Mfg Jul 2025 · Exp Jun 2027 | Diamond Drugs Pvt. Ltd 94West Bengal | The sample does not conform to claim with respect to test for Microbial Limits.Microbial limits | CDL, KolkataCDSCO lab |
| Kufnas-Am Syrup (Ambroxol, Terbutaline, Sulphate, Guaiphenesin & Menthol Syrup) | Batch SL241158TMfg Dec 2024 · Exp Nov 2026 | Star Filteration SystemsHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Khasigo-LS Syrup (Levosalbutamol Sulphate, Ambroxol Hydrochloride Guaiphenesin Syrup) | Batch SP244505Mfg Dec 2024 · Exp Nov 2026 | Sotac Pharmaceuticals Pvt. LtdGujarat | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| KAAMRAJ Caspules (Suspected to contain Sildenafil and Tadalafil | Batch BAC0005Mfg Nov 2024 · Exp Oct 2027 | Brahmanand Ayurveda (OPC) Pvt. LtdPunjab | IdentificationIdentification | SDTL, PunjabState lab |
| Itraconazole Capsules BP 200 mg (Itradot-200 Capsules) | Batch ALC-1509Mfg Dec 2024 · Exp Nov 2026 | Access Life ScienceHimachal Pradesh | Test for DissolutionDissolution | DTL, Bengaluru, KarnatakaState lab |
| Intraconazole Capsules 100 mg (ITRASEC-100) | Batch C24I028DMfg Sep 2024 · Exp Aug 2026 | Bajaj FormulationsUttarakhand | The sample does not conform to I.P. Addendum 2024 with respect to the Dissolution of Itraconazole.Dissolution | CDL, KolkataCDSCO lab |
| Ibuprofen and Paracetamol Tablets IP | Batch NCJ-02Mfg Apr 2025 · Exp Mar 2027 | Agron Remedies Pvt. Ltd. SarverkheraUttarakhand | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua,Jammu and KashmirState lab |
| Hyoscine Butylbromide & Paracetamol Tablets (Hyofem) | Batch GENT10520Mfg Mar 2025 · Exp Feb 2027 | Gentech Healthcare Pvt Ltd | Assay and DescriptionAssay | DTL, JaipurState lab |
| Glucosamine Sulphate Potassium Chloride, Msm With Diacerein Tablets (LYCEREIN PLUS) | Batch LYP-2503Mfg Aug 2025 · Exp Jul 2027 | Life Line PharmaPuducherry | Incorrect labellingLabelling | DTL, PuducherryState lab |
| Glimpiride Tablets I.P. 2 MG. | Batch SGYT-134Mfg Mar 2025 · Exp Feb 2027 | Marc Lifesciences SikkimSikkim | The sample does not conform to I.P. Standard with respect to descriptive Part of the Tablet.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab |
| Glimpiride Tablets I.P. 2 MG. | Batch SGYT-120Mfg Feb 2025 · Exp Jan 2027 | Marc Lifesciences SikkimSikkim | The sample does not conform to I.P. Standard with respect to descriptive Part of the Tablet.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab |
| Glimpiride Tablets I.P. 2 MG. | Batch SGYT-122Mfg Feb 2025 · Exp Jan 2027 | Marc Lifesciences SikkimSikkim | The sample does not conform to I.P. Standard with respect to descriptive Part of the Tablet.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab |
| Glimpiride Tablets I.P. 1 MG. | Batch SLY-108Mfg Sep 2024 · Exp Aug 2026 | Marc Lifesciences SikkimSikkim | The sample does not conform to I.P. Standard with respect to descriptive Part of the Tablet.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab |
| Glimilive-M2 (Glimepiride and Metformin Hydrochloride Prolonged Release Tablets IP) | Batch G522501BMfg Feb 2025 · Exp Jan 2027 | Lifecare Formulations Pvt. LtdPuducherry | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Glimepiride, Pioglitazone & Metformin (Extended Release) Tablets (AXYLIM-PM 1 Tablets) | Batch 424-73Mfg Jan 2024 · Exp Jun 2026 | Zee Laboratories 47Himachal Pradesh | The sample does not conform to claim as per Manufacturer Specification with respect to the test for "Assay" of Pioglitazone Hydrochloride equivalent to Pioglitazone.Assay | RDTL, GuwahatiCDSCO lab |
| Glimepiride Tablets IP (Glimilex 1) | Batch V24457Mfg Nov 2024 · Exp Oct 2026 | APY PharmaAssam | Sample fail the test Dissolution as per IPDissolution | DTL, Thiruvananthapuram, KeralaState lab |
| Frusemide Tablets IP 40 mg | Batch T021906-25Mfg Jun 2025 · Exp May 2027 | Adsila organics Pvt Ltd. Liwaspur roadHaryana | The sample does not conform to claim as per IP 2022 in respect to the Test of Dissolution.Dissolution | RDTL, ChandigarhCDSCO lab |
| Flupentioxol & Melitracen Tablets (Flupen-Clam) | Batch TSF-D0651Mfg Mar 2025 · Exp Feb 2027 | Spen Formulations Pvt. Ltd | The sample does not conform to the claim with respect to Assay of Flupentixol.Assay | DTL, JaipurState lab |
| Ferric-XT Syrup (Ferrous Ascorbate IP Folic Acid IP Syrup) | Batch DL 3214Mfg Oct 2024 · Exp Sep 2026 | Dexter Formulation Pvt. Ltd | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Fenofibrate Tablets I.P. 160 mg | Batch MT250955Mfg Mar 2025 · Exp Feb 2027 | Mascot Health Series Pvt. LtdUttarakhand | The sample does not comply as per I.P. 2022 with respect to the test for "Dissolution" of Fenofibrate.Dissolution | RDTL, GuwahatiCDSCO lab |
| FOLIC ACID TABLETS IP 5mg (FOLIC ACID TABLETS IP 5mg) | Batch TFN25012ALMfg Jul 2025 · Exp Jun 2027 | Hindustan Laboratories LimitedMaharashtra | Uniformity of contentUniformity of weight/content | SDTL, PunjabState lab |
| Everan (Paracetamol Injection 75mg/ml) | Batch EL2PC-07Mfg Dec 2024 · Exp Nov 2026 | Bio Medica Laboratories Pvt. LtdMadhya Pradesh | Test for SterilitySterility | DTL, Bengaluru, KarnatakaState lab |
| Esyfol-XT (Calcium Carbonate, Vitamin D3, Methylcobalamin, L-Methylfolate Calcium & Pyridoxal-5 Phosphate Tablets) | Batch GFTP25214Mfg May 2025 · Exp Apr 2027 | Genip Formulations Pvt. LtdHimachal Pradesh | Test for Uniformity of weight? and does not conform to label claim with respect to ?Assay for Vitamin D3Assay | DTL, Bengaluru, KarnatakaState lab |
| Drotaverine Hydrochloride & Mefenamic Acid Tablets (SPASMIC) | Batch UT6035Mfg May 2024 · Exp Apr 2027 | Uttaranchal Pharmaceuticals Pvt Ltd. Kh No. 673Uttarakhand | The Sample does not conform to the claim with respect to colour presence of Quinoline Yellow in place of Erythrosine on label claimLabelling | DTL, JaipurState lab |
| Doxycycline Capsules IP 100mg | Batch DXC24014Mfg Jun 2024 · Exp May 2027 | Vivek Pharmachem (India) LtdRajasthan | Test for Uniformity of Weight of CapsulesUniformity of weight/content | DTL, JaipurState lab |
| Docetaxel Injection IP (Adoxi)Combipack of (a) 1 vial of Docetaxel Injection IP (50mg in 2ml) | Batch (a) 8DTI2401V (b) 8SLI2401YMfg ? · Exp ? | Beta Drugs Ltd. Kharuni Lodhimajjra RoadHimachal Pradesh | fail the test AssayAssay | DTL, Thiruvananthapuram, KeralaState lab |
| Docetaxel Injection IP (ADOXI) [Combipack of (a) 1 vial of Docetaxel Injection IP (20mg in 0.5ml) | Batch (a)BDTI2401ZA, (b) BSLI2402ZMfg ? · Exp ? | Beta Drugs Ltd. Kharuni Lodhimajjra RoadHimachal Pradesh | fail the test AssayAssay | DTL, Thiruvananthapuram, KeralaState lab |
| Dicyclomine hydrochloride & Mefenamic Acid Tablets IP | Batch WT-1025Mfg Aug 2025 · Exp Jul 2027 | Wilcure Remedies Pvt LtdMadhya Pradesh | The cited product is official in I.P which is not printed on the strips of above refered sample.Other | SDTL, PunjabState lab |
| Dicyclomine hydrochloride & Mefenamic Acid Tablets | Batch WT-1026Mfg Aug 2025 · Exp Jul 2027 | Wilcure Remedies Pvt LtdMadhya Pradesh | The cited product is official in I.P which is not Printed on the strips of above refered sample.Other | SDTL, PunjabState lab |
| Dicvis Gel (Diclofenac Diethylamine, Methyl Salicylate, Linseed Oil & Menthol Gel) | Batch FDE581Mfg Feb 2024 · Exp Jan 2026 | Fine Drugs & Skin CareHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Diclofenac Sodium Tablets IP 50mg(Reactin 50) | Batch G25RDA016Mfg Mar 2025 · Exp Feb 2027 | Acme Generics Private LimitedHimachal Pradesh | Sample fail the test DissolutionDissolution | DTL, Thiruvananthapuram, KeralaState lab |
| Diclofenac Sodium Tablets I.P. 50 mg | Batch DT24-62Mfg Oct 2024 · Exp Sep 2026 | Leostar Healthcare Pvt. LtdTelangana | Disintegration and DescriptionDescription | DCL TelanganaState lab |
| Diclofenac Potassium and Paracetamol Tablot (LIFOGESIC) | Batch 142Mfg Nov 2023 · Exp Oct 2026 | Rajdip PharmaceuticalsGujarat | Description and Test for Uniformity Weight of TabletsDescription | DTL, Bengaluru, KarnatakaState lab |
| Dextromethorphan HBr, Chlorpheniramine Maleate, Phenylephrine HCl Syrup (GESIDRYL DMR Cough Syrup) | Batch S-715Mfg Jun 2025 · Exp May 2027 | Alpha Pharmaceuticals 41Haryana | The sample does not conform to claim with respect to "Assay of Phenylephrine Hydrochloride".Assay | CDL, KolkataCDSCO lab |
| Dexamethasone Tablets IP 0.5mg | Batch TA24665Mfg Aug 2024 · Exp Jul 2026 | Saintlife Pharmaceuticals LtdUttarakhand | Dissolution & ContentDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Dexamethasone Tablets IP (Doxomax) | Batch T-16976Mfg Mar 2025 · Exp Feb 2027 | 38Uttarakhand | The sample does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab |
| Dexamethasone Sodium Phosphate Injection IP (Dexona) | Batch N400726Mfg Jun 2023 · Exp Nov 2025 | Zydus Healthcare LimitedGujarat | Assay and Particulate matter, of Description.Assay | CDL, KolkataCDSCO lab |
| Deflazacort Tablets (Shedef) | Batch MDT-3876Mfg Mar 2025 · Exp Feb 2027 | Mayasha LifesciencesHimachal Pradesh | Assay of Deflazacort. 3.45mg (57.5%) found as claimed 6 mg)Assay | DTL Baddi H.PState lab |
| Dazfol-D Softgel Capsules (Methylcobalamin, Pyridoxine Hydrochloride, Docosahexaenoic Acid (DHA) & Folic Acid Softgel Capsules) | Batch ALD5090EMfg Feb 2025 · Exp Jan 2027 | Amster LabsHimachal Pradesh | Assay for Pyridoxine HydrochlorideAssay | DTL, Bengaluru, KarnatakaState lab |
| DICLOFIT Plus (Diclofenac Sodium & Paracetamol Tablets IP) | Batch M-9475Mfg Jan 2025 · Exp Dec 2026 | Herb Edge Healthcare Pvt. Ltd | Test for Uniformity of weight? onlyUniformity of weight/content | DTL, Bengaluru, KarnatakaState lab |
| DENOCK N | Batch SLTC24010Mfg Mar 2024 · Exp Feb 2026 | Swift Life Sciences Pvt. LtdUttarakhand | The content of Naloxone found to be 0.1169 mg per tablet (116.9%) labelled claim of 0.1mg per tabletLabelling | SDTL, PunjabState lab |
| Compound Sodium Lactate InjectionI.P. (Ringer Lactate Solution for Injection) (RL 500ml) | Batch CG240705033Mfg Jul 2024 · Exp Jun 2027 | Vision Parental Pvt. Ltd | The sample does not conform to I.P. with respect to test for Sterility.Sterility | CDL, KolkataCDSCO lab |
| Compound Benzoin Tincture I.P | Batch TB132Mfg Jan 2025 · Exp Dec 2026 | Apex Healthcare | Tests for weight per ml. Total solids and Assay for Total balsamic Acids (as Cinnamic Acid)?Assay | DTL, Bengaluru, KarnatakaState lab |
| Coldrif Syrup (Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Syrup) | Batch SR-13Mfg May 2025 · Exp Apr 2027 | Sresan Pharmaceutical ManufacturerKarnataka | AdulteratedAdulterated | Drugs Testing Laboratory, Chennai-06State lab |
| Co-Trimoxazole Tablets IP (Sevzole) | Batch CHT23515Mfg Jan 2024 · Exp Dec 2025 | Cureza Healthcare Pvt Ltd. A.B Road | DescriptionDescription | FDAL, MumbaiState lab |
| Clopidogrel and Aspirin Tablets IP (75 mg/75 mg) | Batch Z24-293Mfg Apr 2024 · Exp Mar 2026 | Zee Laboratories Ltd. Behind 47Himachal Pradesh | The sample does not conform to I.P with respect to DissolutionDissolution | CDL, KolkataCDSCO lab |
| Clopidogrel Tablets IP (Lavix-75) | Batch 52-018Mfg Sep 2024 · Exp Aug 2027 | Signature Phytochemical Industries 122Uttarakhand | The sample does not conform to I.P 2022 with respect to the test test for DissolutionDissolution | CDTL, IndoreCDSCO lab |
| Cloberasol Propionate and Salicylic Acid Ointment | Batch 1210CSOMfg Mar 2025 · Exp Feb 2027 | Unicure India LtdUttar Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Clobazam Tablets IP 5 mg | Batch 01283Mfg Sep 2024 · Exp Aug 2026 | Healthy Life Pharma Pvt. Ltd. Factory : N ? 31/1Maharashtra | The sample does not conform to claim as per IP 2022 in respect to the Test of DissolutionDissolution | CDL, KolkataCDSCO lab |
| Ciprofloxacin Tablets IP 500 mg | Batch TB250356Mfg May 2025 · Exp Apr 2027 | Agron Remedies Pvt. Ltd. SarverkheraUttarakhand | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua,Jammu and KashmirState lab |
| Cinchocaine Hydrochloride EP | Batch DH/001/01/24Mfg Jan 2024 · Exp Dec 2028 | Pioneer Agro Industries Sanvin Laboratories Pvt LtdMaharashtra | The sample received does not conform to EP-11 with respect to the test for Related substances..Related substances | CDTL, MumbaiCDSCO lab |
| Chlorpheniramine Tablets IP 4mg | Batch T-6763Mfg Aug 2025 · Exp Jul 2027 | Jackson Laboratories Pvt. Ltd | Failed in DissolutionDissolution | DTL, PuducherryState lab |
| Cefpodoxime Proxetil Tablets IP 200mg | Batch MBT 24019Mfg Jun 2024 · Exp May 2026 | Mancare Laboratories Pvt. LtdUttarakhand | It fails the test Dissolution as per IPDissolution | DTL, Thiruvananthapuram, KeralaState lab |
| Cefpodoxime Proxetil Tablets I.P. 200 mg (Cefporeg-200) | Batch APT24-017Mfg Apr 2024 · Exp Mar 2026 | Regal Laboratories | Test for DissolutionDissolution | DTL, Bengaluru, KarnatakaState lab |
| Cefpodoxime Proxetil & Potassium Clavulanate Tablets IP (Efodoxime-CV Tablets) | Batch MYRTAB-655Mfg Sep 2024 · Exp Feb 2026 | Mayer LabHimachal Pradesh | Assay for Clavulanic AcidAssay | DTL, Bengaluru, KarnatakaState lab |
| Cefixime, Azithromycin & Lactic Acid Bacillus Tablets (CEFICO- AZ TABLETS) | Batch AP-241242Mfg Jan 2025 · Exp Dec 2026 | Park Pharmaceuticals 272 Ind. Area Phase IIHaryana | AssayAssay | SDTL Raipur ChhattisgarhState lab |
| Carbamazepine Tablets IP | Batch GFTP25317Mfg May 2025 · Exp Apr 2027 | Genip Formulations Pvt. LtdHimachal Pradesh | Assay for CarbamazepineAssay | SDTL,Andhra Pradesh, VijayawadaState lab |
| Calcium and Vitamin D3 Tablets. I.P | Batch CBT-0037Mfg May 2025 · Exp Oct 2026 | Crossia Biotech Pvt.Ltd | The sample does not comply as per I.P. 2022 with respect to the test for "Dissolution" of CalciumDissolution | Drugs Testing Laboratory,MeghalayaState lab |
| Calcium and Vitamin D3 Tablets IP(Calse-D3) | Batch CHPLT562Mfg Dec 2024 · Exp May 2026 | Cureza Healthcare Pvt. LtdMadhya Pradesh | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium and Vitamin D3 Tablets IP (Tricium-XT) | Batch 1250077Mfg Jan 2025 · Exp Jun 2026 | Corona Remedies Pvt. LtdHimachal Pradesh | Assay for Vitamin D3Assay | DTL, Bengaluru, KarnatakaState lab |
| Calcium and Vitamin D3 Tablets IP (Calse-D3) | Batch CHPLT538Mfg Dec 2024 · Exp May 2026 | Cureza Healthcare Pvt. LtdMadhya Pradesh | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium and Vitamin D3 Tablets I.P. 500mg/250 I.U | Batch OJCT-009Mfg Dec 2024 · Exp Nov 2026 | Laborate Pharmaceuticals India LtdHimachal Pradesh | Assay for Vitamin D3Assay | DTL, Bengaluru, KarnatakaState lab |
| Calcium and Vitamin D3 Tablets I.P. (Crosscal-D) | Batch CBT-0037Mfg May 2025 · Exp Oct 2026 | Crossasia Biotech Pvt. Ltd | The sample does not comply as per I.P. 2022 with respect to the test for "Dissolution" of Calcium.Dissolution | RDTL, GuwahatiCDSCO lab |
| Calcium Gluconate Injection USP 10% w/v | Batch KBU24001Mfg Sep 2025 · Exp Aug 2027 | Farbe Firma Pvt. LtdGujarat | The sample received does not conform to the I.P. 2022 standard with respect to the test for Bacterial endotoxins, Particulate contamination and Sterility.Sterility | CDTL, MumbaiCDSCO lab |
| Calcium Carbonate 500 MG + VIT. D3 250 IU Tablets IP (CALXIA 500 TABLETS) | Batch GTA1352Mfg Jan 2025 · Exp Dec 2026 | Gidsha PharmaceuticalsGujarat | The sample does not conform to claim as per IP 2022 in respect to the Test of DissolutionDissolution | CDL, KolkataCDSCO lab |
| Calcium Carbonate 500 MG + VIT. D3 250 IU TABLETS IP (CALXIA 500 TABLETS) | Batch GTA1351Mfg Jan 2025 · Exp Dec 2026 | Gidsha PharmaceuticalsGujarat | The sample does not conform to claim as per IP 2022 in respect to the Test of DissolutionDissolution | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets IP (SENCAL - 500) | Batch GT-240203Mfg Nov 2024 · Exp Oct 2026 | Helax Health Care Pvt. LtdUttarakhand | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets IP (SENCAL - 500) | Batch GT-240202Mfg Nov 2024 · Exp Oct 2026 | Helax Health Care Pvt. LtdUttarakhand | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets IP (SENCAL - 500) | Batch GT-240219Mfg Nov 2024 · Exp Oct 2026 | Helax Health Care Pvt. LtdUttarakhand | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets IP (SENCAL - 500) | Batch GT-240204Mfg Nov 2024 · Exp Oct 2026 | Helax Health Care Pvt. LtdUttarakhand | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets I.P (DPCAL-500) | Batch GT17894CMfg Feb 2025 · Exp Jan 2027 | J.M. LaboratoriesHimachal Pradesh | Test for Dissolution for Calcium and Assay for Vitamin D3Assay | DTL, Bengaluru, KarnatakaState lab |
| Calcium Carbonate & Vitamin D3 Tablets (TISE-CAL) | Batch M24097Mfg Sep 2024 · Exp Feb 2026 | Mercury PharmaceuticalsHimachal Pradesh | The sample does not conform to claim as per IP 2022 With respect to AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets (TISE-CAL) | Batch M24120Mfg Nov 2024 · Exp Apr 2026 | Mercury PharmaceuticalsHimachal Pradesh | The sample does not conform to claim as per IP 2022 With respect to AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets (TISE-CAL) | Batch M24099Mfg Sep 2024 · Exp Feb 2026 | Mercury PharmaceuticalsHimachal Pradesh | The sample does not conform to claim as per IP 2022 With respect to AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets (Aemcal-D3) | Batch VDFT-270Mfg Dec 2024 · Exp Nov 2026 | Vzoic Healthcare Pvt. LtdPunjab | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets (Aemcal-D3) | Batch VDFT-269Mfg Dec 2024 · Exp Nov 2026 | Vzoic Healthcare Pvt. LtdPunjab | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets (Aemcal-D3) | Batch VDFT-271Mfg Dec 2024 · Exp Nov 2026 | Vzoic Healthcare Pvt. LtdPunjab | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets (Aemcal-D3) | Batch VDFT-274Mfg Dec 2024 · Exp Nov 2026 | Vzoic Healthcare Pvt. LtdPunjab | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets (Aemcal-D3) | Batch VDFT-273Mfg Dec 2024 · Exp Nov 2026 | Vzoic Healthcare Pvt. LtdPunjab | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets (Aemcal-D3) | Batch VDFT-272Mfg Dec 2024 · Exp Nov 2026 | Vzoic Healthcare Pvt. LtdPunjab | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate 500 MG + VIT. D3 250 IU Tablets IP (Calxia500) | Batch GTA1340Mfg Jan 2025 · Exp Dec 2026 | Gidsha PharmaceuticalsGujarat | The sample does not conform to IP with respect to test for DissolutionDissolution | CDL, KolkataCDSCO lab |
| Calcium Carbonate 500 MG + VIT. D3 250 IU Tablets IP (CALXIA 500) | Batch GTA1354Mfg Jan 2025 · Exp Dec 2026 | Gidsha PharmaceuticalsGujarat | The sample does not conform to IP with respect to the Test of DissolutionDissolution | CDL, KolkataCDSCO lab |
| Calcium Carbonate 500 MG + VIT. D3 250 IU Tablets IP (CALXIA 500) | Batch GTA1348Mfg Jan 2025 · Exp Dec 2026 | Gidsha PharmaceuticalsGujarat | The sample does not conform to claim as per IP 2022 in respect to the Test of DissolutionDissolution | CDL, KolkataCDSCO lab |
| Calcium Carbonate 500 MG + VIT. D3 250 IU Tablets IP (CALXIA 500) | Batch GTA1346Mfg Jan 2025 · Exp Dec 2026 | Gidsha PharmaceuticalsGujarat | The sample does not conform to IP with respect to the Test of DissolutionDissolution | CDL, KolkataCDSCO lab |
| Calcium & Vitamin D3 Tablets IP (500 mg/250IU) | Batch CDA-586Mfg Mar 2025 · Exp Feb 2027 | Healers Lab Unit IIHimachal Pradesh | The sample does not comply as per I.P. 2022 with respect to the Test for "Assay" of Vitamin D3 and "Dissolution" for Calcium.Assay | RDTL, GuwahatiCDSCO lab |
| Calcium & Vitamin D3 Tablets (TISE-CAL) | Batch M24122Mfg Nov 2024 · Exp Apr 2026 | Mercury PharmaceuticalsHimachal Pradesh | The sample does not conform to claim as per IP 2022 with respect to AssayAssay | CDL, KolkataCDSCO lab |
| Calcium & Vitamin D3 Tablets (TISE-CAL) | Batch M24119Mfg Nov 2024 · Exp Apr 2026 | Mercury PharmaceuticalsHimachal Pradesh | The sample does not conform to claim as per IP 2022 with respect to AssayAssay | CDL, KolkataCDSCO lab |
| Calcium & Vitamin D3 Tablets (TISE-CAL) | Batch M24098Mfg Sep 2024 · Exp Feb 2026 | Mercury PharmaceuticalsHimachal Pradesh | The sample does not conform to claim as per IP 2022 with respect to AssayAssay | CDL, KolkataCDSCO lab |
| Calcium & Vitamin D3 Tablets (TISE-CAL) | Batch M24121Mfg Nov 2024 · Exp Apr 2026 | Mercury PharmaceuticalsHimachal Pradesh | The sample does not conform to claim as per IP 2022 with respect to AssayAssay | CDL, KolkataCDSCO lab |
| Buprenorphine and Naloxone Sublingual Tablets IP (Adnomore-N) | Batch ADN5001Mfg Apr 2025 · Exp Feb 2028 | Ethicare Pharmaceuticals (P) LtdGujarat | ContentOther | SDTL, PunjabState lab |
| Buprenorphine and Naloxone Sublingual Tablets IP (Adnomore-N) | Batch ADL5001Mfg Jun 2025 · Exp May 2028 | Ethicare Pharmaceuticals (P) LtdGujarat | ContentOther | SDTL, PunjabState lab |
| Buprenorphine and Naloxone Sublingual Tablets IP | Batch QP-250411Mfg May 2025 · Exp Apr 2027 | QUBIT Pharmaceuticals Pvt. Ltd | ContentOther | SDTL, PunjabState lab |
| Buprenorphine and Naloxone Sublingual Tablets IP | Batch ATN5006Mfg Jul 2025 · Exp Jun 2028 | Ethicare Pharmaceuticals (P) LtdGujarat | ContentOther | SDTL, PunjabState lab |
| Buprenorphine and Naloxone Sublingual Tablets IP | Batch ATN4007Mfg Aug 2024 · Exp Jul 2027 | Ethicare Pharmaceuticals (P) LtdGujarat | ContentOther | SDTL, PunjabState lab |
| Buprenorphine and Naloxone Sublingual Tablets IP | Batch ATL4001Mfg Mar 2024 · Exp Feb 2027 | Ethicare Pharmaceuticals (P) LtdGujarat | ContentOther | SDTL, PunjabState lab |
| Buprenorphine and Naloxone Sublingual Tablets I.P. 2mg+0.5mg ((Akknck-N)) | Batch SLTG25022Mfg Jul 2025 · Exp Jun 2027 | Swift Life Sciences Pvt. LtdUttarakhand | ContentOther | SDTL, PunjabState lab |
| Bupivacaine Injection IP | Batch L2022410BMfg Oct 2024 · Exp Sep 2026 | Protech Telelinks Mouza OgliHimachal Pradesh | The sample does not conform to claim as per IP 2022 in respect to the Test of Particulate matter, DescriptionDescription | CDL, KolkataCDSCO lab |
| Bupivacaine Hydrochloride in Dextrose Injection USP (Bupivacaine Heavy) | Batch I-1468Mfg May 2024 · Exp Apr 2026 | Jackson Laboratories Pvt.Ltd 22-24Punjab | The sample does not conform to U.S.P. with respect to Assay of Dextrose.Assay | CDL, KolkataCDSCO lab |
| Baptar NM Tablet (Pregabalin Methylcobalamin & Nortriptyline Tablets) | Batch UGT-25134EMfg Jan 2025 · Exp Dec 2026 | Ultra Drugs Pvt. LtdHimachal Pradesh | AssayAssay | DTL Baddi H.PState lab |
| BUPRENORPHINE 0.4MG & NALAXONE 0.1MG TABLETS I.P (ADDNOK-N) | Batch 29112504Mfg May 2025 · Exp Apr 2028 | Rusan Pharma LtdUttarakhand | ContentOther | SDTL, PunjabState lab |
| BUPERA N LITE | Batch SLTE25016Mfg May 2025 · Exp Apr 2027 | Swift Life Sciences Pvt. LtdUttarakhand | The content of Naloxone found to be 0.112mg/tablet (112%) against labelled claim of 0.1mg/tablet.Labelling | SDTL, PunjabState lab |
| BIONAC-SPAS | Batch BT-2947Mfg Oct 2024 · Exp Sep 2027 | Biosearch Organics D.I.C. Indl. Estate | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua,Jammu and KashmirState lab |
| Azithromycin Tablets I.P (Morzith-500 Tablets) | Batch T-220124Mfg Jan 2024 · Exp Dec 2026 | Dr. Jee Pharma Pvt LtdUttarakhand | The Sample does not conform to I.P specification with respect to identification and content of AzithromicynIdentification | BDCL, PATNAState lab |
| Azithromycin Oral Suspension IP (AZAM-200) | Batch JL-2538Mfg Sep 2025 · Exp Aug 2027 | Jainsons HealthcareUttarakhand | The sample does not conform to I.P.2022 with respect to test for "Assay of Azithromycin"Assay | CDTL, MumbaiCDSCO lab |
| Azini-100 Suspension (Azithromycin Suspension) | Batch DL0028Mfg Jul 2025 · Exp Jun 2027 | Dexter Formulation Pvt. Ltd | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Atorvastatin Tablets IP 20 mg | Batch STTC-06Mfg Mar 2025 · Exp Feb 2027 | Nestor Pharmaceuticals Limited 11Haryana | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua,Jammu and KashmirState lab |
| Atorvastatin Tablets IP 10mg | Batch CT240238AMfg Jul 2024 · Exp Jun 2026 | Candour PharmaceuticalsHimachal Pradesh | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Atorest 10 (Atorvastatin Tablets IP) | Batch BRD250018Mfg Apr 2025 · Exp Mar 2027 | BRD Medilabs (Unit-II)Himachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Atenolol Tablets IP 50 mg | Batch NHD25365AMfg May 2025 · Exp Apr 2027 | Nest Healthcare Pvt.LtdGujarat | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Aspirin Gastro-Resistance and Atorvastatin Capsules IP (75mg+10mg) | Batch WC022502Mfg Feb 2025 · Exp Jan 2027 | Weldow Remedies | Sample fail the test Dissolution and Related substanceDissolution | RDTL, Ernakulam, KeralaState lab |
| Arik Syrup (Ambroxol Hydrochloride, Phenylephrine Hydrochloride, chlorpheniramine Maleate Guaiphenesin & Menthol Syrup) | Batch 624-732Mfg Oct 2024 · Exp Sep 2026 | Zee Laboratories LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Amyclox TM-LB Capsules | Batch BC002411Mfg Nov 2024 · Exp Oct 2026 | Asian Pharma Kh. No -105-106Himachal Pradesh | NSQOther | DTL Baddi H.PState lab |
| Amoxycillin Clavulanic Acid Tablet (A Cipex-625) | Batch 9421Mfg Apr 2025 · Exp Mar 2027 | Apex FormulationsHimachal Pradesh | The Sample does not conform to I.P specification with respect to identification and content of Amoxycillin and Clavulanic AcidIdentification | BDCL, PATNAState lab |
| Amoxycillin & Potassium Clavulante Tablets IP (Worclav-625) | Batch MICTAB-2359Mfg Apr 2025 · Exp Sep 2026 | Micro FormulationHimachal Pradesh | Sample fail the test Dissolution and Assay of Claculanic AcidAssay | RDTL, Ernakulam, KeralaState lab |
| Amoxycillin & Potassium Clavulanate Injection I.P. | Batch 324-869Mfg Jul 2024 · Exp Jun 2026 | Zee Laboratories Ltd. Behind 47Himachal Pradesh | The sample does not conform to claim as per I.P. 2022 with respect to the test for "Assay" of Amoxycillin and Clavulanic Acid.Assay | RDTL, GuwahatiCDSCO lab |
| Amoxicillin and Potassium Clavulanate Tablet I.P. (Clavam-625) | Batch 24441792Mfg May 2024 · Exp Oct 2025 | Alkem Health ScienceSikkim | The sample does not conform to I.P. with respect to Identification and content of Amoxicillin and Clavulanic Acid.Identification | BDCL, PATNAState lab |
| Amlodipine Tablets IP 5mg | Batch 24110214Mfg Aug 2024 · Exp Jul 2027 | Mercury Laboratories LimitedGujarat | The sample does not conform to the IP with respect to Assay.Assay | DTL, JaipurState lab |
| Amlodipine Besylate and Atenolol Tablets | Batch NPD-6637Mfg Jan 2024 · Exp Dec 2025 | Nuvista Pharmaceuticals Pvt.LtdTelangana | MISBRANDED The product label should be mentioned as Amlodipine besylate and Atenolol tablets IP. But the label is mentioned as Amlodipine besylate and Atenolol tablets only.Misbranded | DCL TelanganaState lab |
| Amlodipine Besylate Tablets IP 5mg (AMLOGEN-5) | Batch 24230171Mfg Aug 2024 · Exp Jul 2026 | Alkem Laboratories LtdHimachal Pradesh | Incorrect labellingLabelling | DTL, PuducherryState lab |
| Amikacin Sulphate Injection IP (Amised 100) | Batch V250114AMfg Jan 2025 · Exp Dec 2026 | Oscar Remedies Pvt. Ltd | Test for SterilitySterility | DTL, Bengaluru, KarnatakaState lab |
| Amikacin Sulphate Injection I.P. 2 ml | Batch AS-2401Mfg Aug 2024 · Exp Jul 2026 | Konis Pharmaceuticals Krishna Nagar-522502 (A.P.) | Description and Particulate matterDescription | CDL, KolkataCDSCO lab |
| Ambroxol Hydrochloride, Guaiphensin, terbutaline Sulphate & Menthol Syrup (KLEANKOF-PLUS SYRUP) | Batch GL-25045AMfg May 2025 · Exp Apr 2027 | Go-ish Remedies Limited (Unit-II)Himachal Pradesh | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Ambroxol HydrochlorideAssay | RDTL, ChandigarhCDSCO lab |
| Ambroxol Hydrochloride 15mg, Terbutaline Sulphate 1.25 mg, Guaiphenesin 50 mg, Menthol 0.5 mg (NUREX-AP) | Batch NRA-2403Mfg Dec 2024 · Exp Nov 2026 | Apple Formulations Pvt. LtdUttarakhand | Assay of Ambroxol HCl (81.53%) & Terbutaline Sulphate (74.40 %)Assay | DTL Baddi H.PState lab |
| Aluminium Hydroxide, Magnesium Hydroxide, Dimethicone & Oxethazine Suspension) | Batch CL240052AMfg Mar 2024 · Exp Feb 2026 | Candour PharmaceuticalsHimachal Pradesh | Assay for Dried Aluminium HydroxideAssay | DTL, Bengaluru, KarnatakaState lab |
| Alpha Lipoic Acid 300mg & Methylcobalamin 1500mcg Capsules (KOBALA PLUS) | Batch DAL401Mfg Jul 2024 · Exp Jun 2026 | Synmedic LaboratoriesRajasthan | The sample does not conform to claim in respect to the test of DescriptionDescription | DTL, JaipurState lab |
| Albendazole Tablets IP 400mg | Batch LMT240917Mfg Aug 2024 · Exp Jan 2027 | Life Max Cancer LaboratoriesUttarakhand | The sample does not conform to the IP with respect to Assay and Dissolution.Assay | DTL, JaipurState lab |
| Albendazole Tablets IP 400 mg (Albekal 400) | Batch ALB05F5AMfg Jun 2025 · Exp May 2027 | Kalpraj Techno Fab Pvt. Ltd | The sample does not conform to I.P. with respect to test for DissolutionDissolution | CDL, KolkataCDSCO lab |
| Albendazole 2.5% W/v oral Suspension | Batch ZAS241002Mfg Oct 2024 · Exp Sep 2026 | Bovine Health care D.No. 5-9-206/2Telangana | MISBRANDED pH does not comply as per IP.pH | DCL TelanganaState lab |
| Aceclofenac, Paracetamol Chlorzoxazone Tablets (Nimal-MR) | Batch DPT-2882Mfg Mar 2024 · Exp Feb 2026 | Dexibo Pharma Pvt. LtdUttarakhand | Failed in DescriptionDescription | DTL, PuducherryState lab |
| Aceclofenac and Paracetamol Tablets(Aceloflam Plus) | Batch AOPT24013SMfg Apr 2024 · Exp Mar 2026 | Shiva Biogenetics Pharmaceuticals Pvt.LtdHimachal Pradesh | AssayAssay | SDTL Raipur ChhattisgarhState lab |
| Aceclofenac and Paracetamol Tablets | Batch CPT946Mfg Sep 2024 · Exp Feb 2027 | Coastal Medicare Pvt. Ltd. RS No. 9/2Andhra Pradesh | MISBRANDED The product label should be mentioned as Acecloenac and Paracetamol Tablets IP. But the label is mentioned as Aceclofenac and Paracetamol Tablets only.Misbranded | DCL TelanganaState lab |
| Aceclofenac & Paracetamol Tablets IP (Bioace-P Tablets) | Batch AT-1872AMfg Apr 2025 · Exp Mar 2027 | Azot Life SciencesHimachal Pradesh | The Sample Received Does Not Conform To I.P. Addendum 2024 Specification With Respect To The Test For Dissolutions For Aceclofenac And Paracetamol Only.Dissolution | CDTL, HyderabadCDSCO lab |
| Acclofenac, Paracetamol & Serratiopeptidase Tablets(ASPAZ) | Batch MDT-4102Mfg May 2025 · Exp Apr 2027 | Mayasha LifesciencesHimachal Pradesh | The sample does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab |
| ANESTHETIC ANTACID GEL (Medicaine Gel) | Batch PMCG24160Mfg Nov 2024 · Exp Oct 2026 | Aryatech Pharma (P) LtdUttarakhand | Assay for Dried Aluminium HydroxideAssay | DTL, Bengaluru, KarnatakaState lab |
Suspected spurious batches in this alert
| Product | Batch | Labelled manufacturer | Reported by | Firm's reply |
|---|---|---|---|---|
| Trypsin-Chymotrypsin Tablets (Chymoral Forte) | 2KU6L057 | Under Investigation | CDL, Kolkata | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Trypsin-Chymotrypsin Tablets (CHYMORAL FORTE) | 2KU6L030 | Under Investigation | CDL, Kolkata | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Azithromycin I.P 500 mg Tablets (Azithral-500) | 2408000201 | Under Investigation | BDCL, PATNA | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Telmisartan 40 mg and Amlodipine 5 mg Tablets IP (Telma-AM) | 05241217A | Under Investigation | NCT of Delhi | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| BUPRENORPHINE INJECTION - 2ml ((NOOPHIN) | LM 18907 | Under Investigation | CDL, Kolkata | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
Check your medicine. Enter the batch number printed on the strip, bottle or carton to see whether it appears in this or any earlier alert. Check a batch number
Sources
- Regulator
- Regulator
Changelog
- 3 Nov 2026: table generated from the CDSCO NSQ portal export (211 rows). Revised CDSCO lists are diffed on each monthly rebuild.